ROXANNA GUNNELS: Open Payments
NPI 1639778160 · CARMI, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$466 in 23 payments from 8 companies in 2025. Trend: 2023 $284 · 2024 $247 · 2025 $466
Food & beverage: $466
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $187 |
| ABBVIE INC. | 4 | $79 |
| Axsome Therapeutics, Inc. | 3 | $57 |
| AstraZeneca Pharmaceuticals LP | 3 | $49 |
| Collegium Pharmaceutical, Inc. | 2 | $30 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| Exact Sciences Corporation | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
Products named: CAPLYTA, QULIPTA, Auvelity, BREZTRI, Jornay PM, FANAPT, Cologuard Collection Kit, VRAYLAR.
Industry payments across IL — which companies pay providers there.
